AIGH Capital Management’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-106,580
| Closed | -$6.84M | – | 38 |
|
|
2024
Q3 | $6.84M | Buy |
106,580
+5,374
| +5% | +$345K | 1.93% | 10 |
|
|
2024
Q2 | $6.86M | Buy |
101,206
+7,709
| +8% | +$523K | 2.14% | 10 |
|
|
2024
Q1 | $11.2M | Buy |
93,497
+29,656
| +46% | +$3.54M | 3.35% | 4 |
|
|
2023
Q4 | $5.31M | Buy |
63,841
+41,257
| +183% | +$3.43M | 2.1% | 19 |
|
|
2023
Q3 | $1.79M | Sell |
22,584
-4,523
| -17% | -$358K | 0.85% | 33 |
|
|
2023
Q2 | $1.59M | Sell |
27,107
-3,956
| -13% | -$231K | 0.65% | 33 |
|
|
2023
Q1 | $1.34M | Hold |
31,063
| – | – | 0.49% | 41 |
|
|
2022
Q4 | $1.59M | Buy |
31,063
+25,249
| +434% | +$1.3M | 0.53% | 37 |
|
|
2022
Q3 | $586K | Sell |
5,814
-309
| -5% | -$31.1K | 0.18% | 40 |
|
|
2022
Q2 | $1.63M | Hold |
6,123
| – | – | 0.43% | 29 |
|
|
2022
Q1 | $1.26M | Buy |
6,123
+3,134
| +105% | +$646K | 0.31% | 33 |
|
|
2021
Q4 | $596K | Buy |
+2,989
| New | +$596K | 0.18% | 43 |
|